Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound ca… Read more
Shenzhen Lifotronic Technology Co (688389) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.025x
Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has a cash flow conversion efficiency ratio of 0.025x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥53.10 Million) by net assets (CN¥2.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shenzhen Lifotronic Technology Co - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Shenzhen Lifotronic Technology Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shenzhen Lifotronic Technology Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
N/A |
|
Hangzhou Star Shuaier Electric Appliance Co Ltd
SHE:002860
|
-0.007x |
|
GSR III Acquisition Corp. Unit
NASDAQ:GSRTU
|
-0.002x |
|
Veradigm Inc.
NASDAQ:MDRX
|
0.024x |
|
Yuhuan CNC Machine Tool Co Ltd
SHE:002903
|
0.005x |
|
Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares
NASDAQ:ANSC
|
N/A |
|
Titan International Inc
NYSE:TWI
|
0.025x |
|
JSL Construction & Development Co Ltd
TW:2540
|
-0.226x |
Annual Cash Flow Conversion Efficiency for Shenzhen Lifotronic Technology Co (2016–2024)
The table below shows the annual cash flow conversion efficiency of Shenzhen Lifotronic Technology Co from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion | CN¥296.47 Million | 0.145x | -14.41% |
| 2023-12-31 | CN¥1.80 Billion | CN¥303.82 Million | 0.169x | -10.21% |
| 2022-12-31 | CN¥1.44 Billion | CN¥271.71 Million | 0.188x | +30.06% |
| 2021-12-31 | CN¥1.26 Billion | CN¥182.07 Million | 0.145x | +21.33% |
| 2020-12-31 | CN¥1.14 Billion | CN¥136.42 Million | 0.119x | +36.36% |
| 2019-12-31 | CN¥1.05 Billion | CN¥91.82 Million | 0.087x | -27.94% |
| 2018-12-31 | CN¥668.39 Million | CN¥81.14 Million | 0.121x | +102.24% |
| 2017-12-31 | CN¥587.25 Million | CN¥35.25 Million | 0.060x | -20.50% |
| 2016-12-31 | CN¥370.82 Million | CN¥28.00 Million | 0.076x | -- |